GlassScriptPhysician profile
Gregory James Imbarrato
NPI 1619231594
$6,485.18
in general payments reported to CMS, 2019-2025
13 companies · $3,987 in 2025
The $3,987 reported for 2025 was more than what 78% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $488 · 2020: $301 · 2021: $388 · 2022: $372 · 2023: $471 · 2024: $479 · 2025: $3,987.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,560 · Travel and Lodging: $2,377.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,559.77 |
| Travel and Lodging | $2,377.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $5,197.80 | 2021-2025 | Pipeline, Onyx 18, Solitaire X |
| Providence Medical Technology, INC. | $246.54 | 2020 | |
| Medtronic USA, INC. | $207.75 | 2019-2020 | |
| Penumbra, INC. | $183.00 | 2019-2024 | Red 72, Penumbra System |
| Edwards Lifesciences Corporation | $136.00 | 2019 | |
| Stryker Corporation | $122.53 | 2025 | Evolve |
| Osteocentric Technologies, INC. | $99.50 | 2023 | Osteocentric 4.0 X 130mm Locking Bone Screw Fastener St |
| Globus Medical, INC. | $91.96 | 2022-2023 | Hedron Ic |
| Depuy Synthes Sales INC. | $79.55 | 2019-2020 | |
| Terumo Medical Corporation | $57.30 | 2021-2022 | |
| Balt USA, LLC | $26.28 | 2025 | Optima Coil System |
| Scientia Vascular | $19.20 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $17.77 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Imbarrato listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.